Form 4: Verastem Director Sells Shares After Option Exercise

Verastem Director Paul A. Bunn exercised stock options and subsequently sold 6,250 shares of common stock for approximately $10.00 per share under a Rule 10b5-1 plan.

Summary

• Paul A. Bunn, a Director of Verastem, Inc. (VSTM), reported transactions on November 21, 2025.
• He exercised 6,250 stock options at an exercise price of $3.27 per share, acquiring 6,250 shares of common stock.
• Immediately following the exercise, he sold 6,250 shares of common stock at a weighted average price of $10.00 per share, with individual sales ranging from $10.00 to $10.01.
• These transactions were conducted pursuant to a pre-arranged Rule 10b5-1 trading plan.
• After these reported transactions, Mr. Bunn beneficially owns 2,083 shares of Verastem common stock directly and 6,250 stock options directly.

Sentiment

Score: 5

Explanation: Neutral. The transactions are part of a pre-arranged 10b5-1 plan, which mitigates negative sentiment often associated with insider sales. It represents a routine liquidity event for an insider monetizing vested options.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating they were pre-planned and not reactive to immediate market conditions, which can mitigate concerns about opportunistic insider trading.

Negatives

• An insider (Director Paul A. Bunn) sold 6,250 shares of common stock, which could be perceived by some investors as a lack of confidence, despite being part of a pre-arranged plan.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the sale as a signal, but the context of a Rule 10b5-1 plan suggests it is a planned liquidity event rather than a reflection of a change in the company's fundamental prospects.

Next Steps

• The company's 2025 Annual Meeting of Stockholders is mentioned as the final vesting date for some options, indicating a future event.

Key Dates

Recommendation

The Form 4 filing details a pre-scheduled insider transaction (exercise of options and subsequent sale of shares) by a director. Such transactions, executed under a Rule 10b5-1 plan, are generally considered routine liquidity events and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.

Keywords

Verastem, VSTM, Form 4, Insider Trading, Stock Options, Share Sale, Paul A. Bunn, Rule 10b5-1, Director Transaction